Previous Article | Next Article 
Journal of Bacteriology, December 2000, p. 6927-6932, Vol. 182, No. 24
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Pleiotropic Effect of Protein P6 on the Viral
Cycle of Bacteriophage
29
Ana
Camacho and
Margarita
Salas*
Centro de Biología Molecular
"Severo Ochoa" (CSIC-UAM), Universidad Autónoma, Canto
Blanco, 28049 Madrid, Spain
Received 17 July 2000/Accepted 4 October 2000
 |
ABSTRACT |
The product of bacteriophage
29 early gene 6, protein p6, is a
double-stranded-DNA binding protein and one of the more abundant proteins during viral infection. We have studied the role of protein p6
in vivo through the infection of suppressor and nonsuppressor Bacillus subtilis strains with a phage carrying a nonsense
mutation in gene 6, sus6(626). In the absence of functional protein p6, the two major processes of the viral cycle, transcription and DNA
replication, were affected. Viral DNA synthesis was practically abolished, and early transcription was remarkably delayed and, in
addition, underregulated at late times of the infection. The amount of
protein p6 synthesized after infection with mutant phage sus6(626)
under suppressor conditions was sixfold lower than that produced after
wild-type infection. Nonetheless, phage production was as high as that
obtained after wild-type infection. These results indicate that p6 is
synthesized in amounts higher than those needed for most of its
functions. However, the concentration of protein p6 appeared to be
important for repression of the early promoter C2.
 |
INTRODUCTION |
The bacteriophage
29 genome
encodes at least 20 proteins whose genes have been divided into two
groups, early and late, based on the time during infection when they
are first expressed (19) (see Fig. 1). Early genes are
transcribed from three main promoters: C2, A2b, and A2c. The transcript
originating from the C2 promoter encodes proteins p17 and p16.7, which
are involved in viral DNA replication (5, 11), and in
addition, it contains four open reading frames. Transcripts starting at
promoters A2b and A2c give rise to proteins p6 to p1. Protein p1 is
involved in viral DNA replication, and it becomes attached to the
bacterial membrane (4). Genes 2 and 3 encode, respectively,
the viral DNA polymerase and the protein that primes the initiation of
replication and becomes covalently linked to the 5' termini of the
phage DNA (18). The product of gene 4, protein p4, is the
transcriptional regulator of the promoters located in the central
region of the genome. Protein p4 is responsible for the switch from
early to late transcription, repressing early promoters A2b and A2c and
activating late promoter A3 (17). Gene 5 encodes a
single-stranded-DNA binding protein, and the product of gene 6, protein
p6, is a double-stranded-DNA binding protein (18). Late
genes encode structural proteins and proteins involved in viral
morphogenesis and bacterial lysis, and they are transcribed from the
late A3 promoter. Finally, the RNA transcribed from the other main
promoter, A1, is required for the encapsidation of the phage genome
(7).
Protein p6 is a 103-amino-acid, non-sequence-specific DNA binding
protein, able to recognize the phage genome; binding yields a
multimeric complex in which the DNA adopts a right-handed toroidal conformation (9). The in vitro formation of multiple protein p6-DNA complexes, scattered through virtually the entire phage genome,
led to the proposal that protein p6 plays a structural role in the
organization of the viral genome into a compact nucleoprotein complex
(8). Multimeric complexes adopt a variety of dynamic structures that can provide an adequate frame for multiple processes ranging from DNA unwinding to the interaction of proteins with DNA. The
formation of the p6-DNA complex at the phage genome ends, where the
origins of replication and promoter C2 are located, is required in
vitro for activation of the initial step of
29 DNA replication
(24) and for repression of the early promoter C2
(2, 25; A. Camacho and M. Salas, unpublished data).
Furthermore, it is also through the formation of a nucleoprotein
complex that p6 is involved in the regulation of the central promoter
region complementing the transcriptional regulatory function of protein p4 (6). Hence, protein p6 is an interesting candidate for
the study of the function of architectural DNA binding proteins.
In this work we have analyzed viral development in the absence of p6
and in the presence of different amounts of p6 by using a
29 mutant
with a nonsense mutation in gene 6 under nonsuppressor and suppressor
conditions. The results indicate that, in vivo, protein p6 function is
essential both for viral DNA synthesis and for the correct regulation
of the promoters expressed early in infection. Furthermore, results
obtained after infection of suppressor bacteria with mutant sus6(626),
where a functional but reduced synthesis of protein p6 takes place,
indicated that p6 is synthesized in amounts higher than those needed
for most of its functions. However, early promoter C2 repression was
dependent on p6 concentration.
 |
MATERIALS AND METHODS |
Bacterial strains and bacteriophages.
Bacillus
subtilis 110NA Trp
SpoA
su
(15) was used to grow wild-type phage
29, while conditional lethal mutants sus6(626) (16) and
sus14(1242) (10) were propagated in the suppressor strain
MO-101-P SpoA
[Met
]+
Thr
su+44 (12). Bacteria were
grown in Luria-Bertani medium (20) with 5 mM
MgSO4 in phage infection assays. Phage stocks were prepared essentially as described elsewhere (15).
Isolation and analysis of the viral RNA.
Cultures of
B. subtilis su
and su+ strain
exponentially grown to a density of 5 × 108 cells/ml
were infected at the multiplicities of infection (MOIs) indicated
below, with mutant sus6(626) or sus14(1242). Total RNA was isolated
from 20 ml of culture at the times indicated below and purified as
previously described (14). Each RNA species was identified
by the extension of specific primers designed to hybridize downstream
from the transcription start sites of the promoter under study. Primer
positions were 98 nucleotides (nt) from promoter C2, 87 nt from
promoter A2b, 77 nt from promoter A2c, 69 nt from promoter A1, and 68 nt from promoter A3 (Fig. 1). Mixtures of
primers (50 µmol each) were end labeled with 20 U of T4
polynucleotide kinase and 20 µCi of [
-32P]ATP for
1 h at 37°C, precipitated with ethanol, and resuspended in
H2O to a final concentration of 0.2 pM. One microgram of
RNA was mixed with 10 pmol of each 32P-labeled primer in 40 mM Tris-HCl (pH 7.5) and 100 mM NaCl in a final volume of 20 µl.
After denaturation at 85°C for 2 min, hybridization was carried out
by allowing the DNA mixture to cool slowly to 30°C. Samples were then
put on ice, and 120 µl of ice-cooled reverse transcriptase buffer
(Promega) was added. Primers were extended with 5 U of avian
myeloblastosis virus reverse transcriptase (Promega) for 1 h at
42°C. Samples were then filtered through 1-ml Sephadex G-50 spun
columns, and the eluted cDNA was precipitated with ethanol. Truncated
transcripts were analyzed by electrophoresis in 6%
polyacrylamide-urea gels and quantified using a Fuji Bas-IIIs image
analyzer.

View larger version (7K):
[in this window]
[in a new window]
|
FIG. 1.
Transcription map of the bacteriophage 29 genome.
Locations of promoters A1, A2c, A2b, A3, and C2 are indicated by
vertical bars. Arrows indicate the direction of transcription, with the
arrowheads at the termination sites (TA1 and TD1). The genetic map is
depicted. The phage terminal protein (TP) is shown attached to the 5'
ends of the genome.
|
|
In vitro transcription assays.
Runoff transcription assays
(10 µl) contained 25 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 2 mM dithiothreitol, 100 µM (each) CTP, GTP, and ATP, 10 µM UTP, 0.5 µCi of [
-32P]UTP, 1 µg of poly(dI-dC), 4 U of
RNasin, and 50 mM KCl. Each reaction mixture also contained a 4 nM
concentration of a 268-bp DNA fragment containing promoter C2, 25 nM
RNA polymerase (RNAP), and protein p6 in the amounts indicated below.
Reaction mixtures containing DNA, RNAP, and p6 were incubated for 10 min at 37°C before nucleoside triphosphate addition, and
transcription was allowed to proceed for 20 min at 37°C. Reactions
were stopped by the addition of 0.15% sodium dodecyl sulfate (SDS) and
2.5 mM EDTA. Nonincorporated radioactivity was removed with
Sephadex-G50 spun columns. Transcripts were precipitated with ethanol,
resolved on 6% polyacrylamide denaturing gels, and quantified by using a Fuji Bas-IIIs image analyzer.
DNA purification and analysis.
DNA was purified from 1.5 ml
of a culture of B. subtilis infected at an MOI of 5 with
mutant sus6(626) or control phage. Cells were pelleted by
centrifugation and resuspended in 500 µl of buffer BBA (10 mM
Tris-HCl [pH 8], 10 mM EDTA, 50 mM NaCl, 20% sucrose) with 1 mg of
lysozyme and 50 µg of RNase A per ml. After 10 min of incubation at
room temperature, SDS (1.5%) and proteinase K (50 µg/ml) were added
and the samples were incubated for 5 h at 27°C. DNA was
extracted with phenol, precipitated with ethanol, and resuspended in
100 µl of TE (10 mM Tris-HCl [pH 8], 1 mM EDTA). Aliquots of 20 µl were run in 0.6% agarose gels containing ethidium bromide.
Pictures of the gels were taken with a Polaroid machine, and the amount
of viral DNA in each sample was quantified by scanning the picture
negative of the gel with a Molecular Dynamics 300A densitometer.
Analysis of the virus-induced proteins.
Exponentially grown
cultures of 5 × 108 cells of the B. subtilis su
or su+ strain per ml were
infected with the mutant sus6(626) or sus14(1242) at the MOI indicated
for each experiment. At the times indicated below, cells from 1.5-ml
cultures were collected by centrifugation and resuspended in 250 µl
of SDS buffer (625 mM Tris-HCl [pH 6.8], 2% [wt/vol] SDS, 5%
[vol/vol] 2-mercaptoethanol, 10% glycerol). Proteins were separated
in a 10-to-20% SDS-polyacrylamide gel electrophoresis gradient and
stained with Coomassie blue or analyzed by Western blotting. Protein p6
was quantified from the wet Coomassie blue-stained gel by scanning the
band with a Molecular Dynamics 300A densitometer. For Western blot
analysis, proteins were transferred to an Immobilon-P membrane
(Millipore) for 2 h at 200 mA and the assay was carried out
following the instructions of the supplier.
Purification of protein p6.
Exponentially growing B. subtilis su+ cells were infected at an MOI of 5 with
mutant sus6(626). Cells were collected by centrifugation after 45 min
of infection and ground with alumina, and proteins were suspended in
buffer B6 (50 mM Tris-HCl [pH 7.5], 1 mM EDTA, 7 mM
-mercaptoethanol) with 0.8 M NaCl. DNA was removed with 0.3%
polyethylenimine, and protein p6 was precipitated by adjusting the salt
concentration to 0.15 M NaCl with buffer B6 containing 0.004%
polyethylenimine. A further step of precipitation was done by addition
of ammonium sulfate to 70% saturation. Proteins were solubilized in
buffer B6 with 50 mM NaCl and 25% glycerol and passed through a
phosphocellulose column (5 ml) equilibrated in buffer B6 with 50 mM
NaCl. The fraction that had been eluted with 100 mM NaCl was passed
through a DEAE-cellulose column (2 ml), and protein p6 was eluted with
0.5 M NaCl. The protein was dialyzed in buffer B6 containing 50%
glycerol and stored at
70°C. The purity and concentration of p6
were assayed by gel electrophoresis and Coomassie blue staining.
 |
RESULTS |
The function of protein p6 was studied by analyzing the viral
development of a mutant with a nonsense mutation in gene 6, sus6(626),
in suppressor and nonsuppressor B. subtilis strains. In the
nonsuppressor bacteria (su
) the phage development has to
cope with the absence of the gene function, whereas in the suppressor
strain (su+), functionality is at least partially restored.
With the aim of producing viral development without lysis of the
infected bacteria beyond min 40 of the infection, another nonsense
mutant, sus14(1242), was used instead of the wild-type phage for the
control infection. Mutant sus14(1242) does not lyse the bacteria
because it has a termination codon in the coding sequence of the holin
protein; otherwise, it undergoes a normal phage development
(10).
Synthesis of protein p6 in mutant sus6(626) infection.
The
location of the mutation of mutant sus6(626) was determined by
sequencing of its PCR-amplified gene 6. A single base substitution in
codon 30 was found, which changes the CAA triplet coding for glutamine
(Gln30) to the nonsense triplet TAA (data not shown). Thus,
when mutant sus6(626) infects the B. subtilis nonsuppressor
strain 110NA (su
), a truncated peptide containing only
the 29 N-terminal amino acids of p6 should be synthesized. Figure
2 shows that full-size protein p6 was
produced when the sus6(626) mutant infected the suppressor
su+44 strain (su+), as shown by Western blot
analysis; however, the amount of protein was sixfold lower than that
obtained after sus14(1242) phage infection. On the other hand, as
expected, after infection of su
bacteria with mutant
sus6(626), no full-size protein p6 was recognized by the monospecific
anti-p6 serum. Two other early induced proteins were analyzed in this
experiment, p5 and p17, and whereas the amounts of protein p5 were
similar after infection with sus14 and sus6 phage, the amount of p17 in
either su+ or su
cells infected with mutant
sus6(626) was threefold higher than that in control cells infected with
sus14(1242). Results obtained with proteins p2 and p4 were similar to
those for p5. Since genes 2, 3, 5, and 6 are transcribed from promoters
A2b and A2c, while gene 17 is transcribed from promoter C2, this result
could reflect differences in early promoter regulation induced by the
mutation of gene 6.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of protein p6 in B. subtilis
infected with mutant sus6(626). Polypeptides present 40 min after the
infection of suppressor (su+) and nonsuppressor
(su ) B. subtilis with 29 mutants carrying
nonsense mutations in gene 6 (sus6) and gene 14 (sus14) were separated
by electrophoresis in a 10-to-20% gradient polyacrylamide gel in the
presence of SDS. Proteins were transferred to a Millipore
polyvinylidene difluoride membrane, and proteins p5, p6, and p17 were
detected with a mixture of the corresponding monospecific antisera.
|
|
Viral DNA synthesis and transcription in bacteria infected with
mutant sus6(626).
To get further insight into the function(s) of
p6 in vivo, we analyzed the development of mutant sus6(626). Infection
of the nonsuppressor strain (su
) with mutant sus6(626)
gave rise to a remarkable delay of bacterial lysis and a burst size of
about 10 phage particles per bacterium, whereas the burst size was
about 300 virus progeny per cell when mutant sus14(1242) was used
instead. Infection of the suppressor strain (su+) with
mutant sus6(626) produced normal lysis and phage progeny (results not
shown). These results indicate that several steps of the viral
development are affected by the absence of p6.
Previous results have shown that mutant sus6(626) does not incorporate
labeled thymidine when infected su
bacteria are treated
with 6-(p-hydroxyphenylazo)-uracil, indicating that the
mutant is defective in DNA synthesis (5). As shown in Fig.
3, the amount of DNA synthesized by
mutant sus6(626) in su
bacteria infected at an MOI of 5 or 20, analyzed by agarose gel electrophoresis, was very low after 35 min of infection compared with the amount synthesized after infection
with wild-type phage or after infection of su+ bacteria
with the sus6 mutant. In addition, two- and threefold increases in
viral DNA levels were obtained by increasing the MOI from 5 to 20 in
the control wild-type infection and in su+ bacteria
infected with mutant sus6(626), respectively. Therefore, protein p6 is
required for the correct synthesis of phage DNA, and the protein
synthesized by the mutant in the suppressor bacteria fully rescued the
DNA synthesis capacity.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 3.
DNA synthesis in B. subtilis infected with
mutant sus6(626). Agarose electrophoresis of the DNA present after 60 min of infection of nonsuppressor (su ) and suppressor
(su+) B. subtilis with 29 mutants carrying
nonsense mutations in gene 6 (sus6) or gene 14 (sus14). The MOI (phage
per bacterium) is indicated on top of each lane.
|
|
The analysis of protein p6 function in transcription regulation was
followed by analysis of the transcripts produced from each of the five
main viral promoters in a restrictive infection with phage mutant
sus6(626) (Fig. 4). Since RNA synthesis
was quantified by primer extension assays, the results indicate the amount of RNA accumulated but not the turnover rate for each
transcript. During the development of mutant sus14(1242), as it
occurs in a wild-type infection, early transcription is driven
from promoters C2, A2c, and A2b. Promoter C2 can be considered the
earliest transcribed one, since its transcripts are detected first and
reached the maximum by 15 min postinfection, while the accumulation of
the transcripts derived from the other two early promoters, A2b and A2c, did not reach the maximum before 20 to 25 min postinfection. Without functional protein p6 [mutant sus6(626) infecting
su
bacteria], a quite different picture was observed;
the early transcription derived from promoters A2b, A2c, and C2 was low in the first 20 min of the infection, with a dramatic increase at 30 min, reaching a plateau by 35 to 40 min. Since no significant DNA
synthesis was observed in the absence of p6 (Fig. 3), the template for
transcription in this case should be mainly the input DNA, while in a
wild-type infection the newly synthesized DNA molecules are
transcribed, too. Hence, in the absence of p6, the amount of early
transcripts late in infection is severalfold higher than when p6 is
functional, indicating a failure of the repression of the early
promoters A2b, A2c, and C2 at this stage of the infection. Development
of mutant sus6(626) in the su+ bacteria restored the level
of the transcripts derived from promoters A2b and A2c late in infection
and, therefore, the regulation of those promoters. However, the amount
of transcripts from promoter C2 was fivefold higher than after
wild-type infection and the repression was delayed by about 15 min.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Primer extension analysis of the transcripts produced
throughout the infection cycle in B. subtilis infected with
mutant sus6(626). RNA synthesized by mutant sus6(626) in nonsuppressor
(su ) or suppressor (su+) B. subtilis or by the control mutant sus14(1242) at an MOI of 5 was
isolated at the time after the infection indicated at the bottom of
each graph. Transcripts derived from each of the promoters (indicated
above each graph) were analyzed by the extension of radioactively
labeled specific primers and quantitated as described in Materials and
Methods. The graphs show the amount of mRNA observed during an
infection cycle, where each point represents the average of at least
three independent experiments. Arbitrary units are comparable between
graphs.
|
|
Transcription from the other two main promoters, the late A3 promoter
and the constitutively expressed A1 promoter, was also analyzed (Fig.
4). In the control infection, transcripts derived from promoter A1 were
detectable after 10 min of infection, and from then on they accumulated
almost linearly, while the expression of promoter A3 started after 15 min of infection, when the virus-encoded transcription activator,
protein p4, is synthesized (14). There was not much
difference in the level of transcription of promoter A1 in the absence
or presence of p6 synthesis, with about twofold fewer transcripts in
the sus6(626)-infected nonsuppressor bacteria than in those with the
wild-type infection. This does not seem to be significant, taking into
account the above-mentioned defect in DNA synthesis in the
su
bacteria infected with the sus6 mutant; this defect
could be also responsible for the reduced rate of transcription from
the late promoter A3. Transcription from both promoters (A1 and A3) was
restored when the mutant sus6(626) was grown in the suppressor bacteria.
Repression activity of the protein p6 produced in suppressor
bacteria infected with mutant sus6(626).
Most nonsense mutants can
recover the activity of the protein if the tRNA of the suppressor
strain introduces an amino acid homologous to the one originally
mutated, or if the changed amino acid is located in a position which
does not interfere with the structure or activity of the protein.
However, even under favorable conditions of amino acid substitution,
the amount of protein produced in the suppressor strain could be
insufficient if the protein has to function in stoichiometric amounts.
Protein p6, together with the single-stranded-DNA binding protein p5,
is the most abundant protein after
29 infection, the estimated
amount of protein p6 being about 7 × 105 molecules
per cell after 30 min of infection (1). Hence, the deficient
repression of promoter C2 in the suppressor strain infected with mutant
sus6(626) could be due either to the synthesis of a
not-fully-functional protein or to a small amount of synthesis of the
protein. To analyze these possibilities we purified the p6 synthesized
in the su+ strain infected with the sus6(626) mutant and
assayed its ability to repress promoter C2 in vitro. As shown in Fig.
5, the protein expressed from the mutant
was found to have repressor function similar to or even slightly better
than that of the wild-type protein. Thus, the loss of functionality of
protein p6 as a repressor of the C2 promoter in the sus6-infected
suppressor bacteria could be ruled out.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of protein p6 on in vitro transcription of
promoter C2. Runoff assays were performed in the presence of the
indicated amounts of purified protein p6 from a wild-type (wt) phage
infection or purified p6 from B. subtilis su+
infected with the mutant sus6(626) (sus6).
|
|
Relation between concentration of protein p6 and repression of
promoter C2.
The full functionality of protein p6, isolated from
the sus6-infected su+ strain, in the repression of
promoter C2 in vitro indicated that the deficient repression of this
promoter during the development of mutant sus6(626) in su+
bacteria is not due to the amino acid changed by the mutated tRNA.
On the other hand, the amount of protein synthesized after sus6(626)
infection of su+ bacteria was smaller than in the wild-type
infection (Fig. 2). Both data suggest that p6 could function in a
dose-dependent manner in the repression of promoter C2. If this is the
case, since promoter C2 is repressed as early as 15 min postinfection
and p6 is an early protein, infection by mutant sus6(626) at various
MOIs should produce different levels of p6 at early times of the
infection, which would influence the degree of repression of
promoter C2. To test this hypothesis, we infected suppressor bacteria
with mutant sus6(626) at an MOI of 5 or 20, and the levels of
synthesis of protein p6 and of repression of promoter C2 were analyzed
in the same experiment. As shown in Fig.
6, the MOI affected the amount of protein
p6 present in the cells in the first 15 min of the infection, that is,
at the time when promoter C2 is silenced in a wild-type infection (Fig.
4). At 15 min, about fivefold more p6 was present in the extract from
cells infected with the higher MOI. On the other hand, the amount of
the transcripts derived from promoters C2, A2b, and A3 increased with
the genome dose, with about threefold more transcripts at an MOI of 20 than at an MOI of 5 (Fig. 7). The time
kinetics showed analogous curves for the transcripts derived from
promoters A2b and A3 at both MOIs, in contrast to the different
kinetics obtained for promoter C2. At an MOI of 20, repression of the
C2 promoter was stronger and took place by 15 min postinfection, which
is what occurs in wild-type infection (Fig. 3) and which is in
agreement with the increase of p6 synthesis (Fig. 6). Thus, the amount
of p6 seems to be important in repressing promoter C2. This result
suggests a fine tuning of the molecular ratio between the viral genome and protein p6.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of the amount of protein p6 induced as a
function of the MOI with mutant sus6(626). The suppressor B. subtilis strain was infected with mutant sus6(626) at an MOI of 5 or 20, and at the times indicated (in minutes), proteins were analyzed
by SDS-polyacrylamide gel electrophoresis and stained with Coomassie
blue.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 7.
Viral RNA synthesis as a function of the MOI with mutant
sus6(626). RNA derived from the early promoters C2 and A2b or the late
promoter A3 was analyzed by the extension of specific primers
hybridized to transcripts purified from extracts of the suppressor
strain infected with mutant sus6(626) at an MOI of 5 or 20 at the
indicated times.
|
|
 |
DISCUSSION |
From the results presented in this paper, together with previous
ones, we can envision in more detail the role of protein p6 during the
life cycle of bacteriophage
29. Early transcription, driven from
promoters C2, A2b, and A2c, starts as soon as the DNA is injected into
the cell and interacts with the host RNAP. The transcripts expressed
from promoters A2b and A2c end at the termination site TA1, located in
gene 4, or at the DNA end (3) (Fig. 1). Therefore, genes 6 and 5 are expressed from all transcripts derived from these promoters,
while genes 4 to 1 are expressed only from the transcripts passing
through the TA1 terminator. This fact probably contributes to the large
amount of proteins 6 and 5 in the infected cells relative to the level
of the proteins encoded only by the transcripts passing through the TA1
terminator, which include, among others, the transcriptional regulator,
protein p4, and the phage-encoded DNA polymerase. Upon its synthesis, protein p6 binds in a non-sequence-specific manner but with some preference for certain sequences of the phage DNA, such as the nucleation sites located at the genome ends (24). This
interaction of p6 with the DNA might produce a restructuring more
suitable for early transcription, which could explain the delayed
induction of the early promoters in the absence of p6, shown in Fig. 4. Binding of p6 to the nucleation sites facilitates further binding of p6
dimers to DNA, and a multimeric complex is formed that can extend far
from the nucleation site as the synthesis of protein p6 progresses. Our
current model holds that the DNA at these protein-DNA complexes forms a
right-handed coil wrapped around a multimeric protein p6 core
(23). The multimeric complexes formed at the genome ends
activate DNA synthesis (22) and repress promoter C2
(2) located 160 bp from the right DNA end by impairing the stability of the closed complex (Camacho and Salas, unpublished). However, they do not affect the transcription complex formed at promoter A1 located 321 bp from the left DNA end. The different outcomes in the C2 and A1 promoters may depend on the orientation of
the transcription unit relative to the right-handed toroidal conformation of the DNA in the p6-DNA complex. Transcription from promoter C2 is codirectional with p6-DNA complex growth, while the
direction of transcription from promoter A1 is opposite to that of
p6-DNA complex formation. In addition, the distance between the
transcription start site of each promoter and the corresponding nucleation site is three times larger at promoter A1 than at promoter C2. Results presented here show that the amount of protein p6 present
during the first 15 min of the infection is crucial for promoter C2
repression. Since phage-encoded DNA synthesis starts by 15 min of
infection (19), this result suggests that the DNA/p6 ratio
is essential for repression of promoter C2 to start.
Protein p4 is believed to play a major role in the control of promoters
A2b, A2c, and A3. The protein binds upstream of RNAP at promoters A2c
and A3, and by direct interaction of p4 with the RNAP
subunit it
represses promoter A2c, impeding promoter clearance, and activates
transcription from promoter A3, stabilizing the RNAP as a close complex
(17). In addition, p4 plays a major role in the repression
of promoter A2b through its binding to the site upstream of PA3 which
overlaps with the
35 box of PA2b. It has been recently shown that
protein p6 promotes p4-mediated repression of promoter A2c and
activation of promoter A3 by enhancing the capacity of p4 to bind to
the DNA (6). Figure 4 shows that in the wild-type phage
infection, accumulation of transcripts derived from promoters A2b and
A2c is arrested by 25 min and decreases afterwards; in contrast, no
decrease in such transcripts was observed after infection of
su
bacteria with the mutant sus6(626). The impairment on
repression of promoters A2b and A2c seems to be due to deficient
synthesis of protein p6, since activation of promoter A3 indicated the
presence of functional protein p4.
Large amounts of protein p6 accumulate throughout wild-type infection,
suggesting a need for such amounts of the protein for at least some of
its functions. The results presented in this paper suggest that a high
concentration of protein p6 is critical for repressing promoter C2 but
not for its other functions, such as regulation of promoters A2c and
A2b or activation of DNA synthesis. Since for repression of promoters
A2b and A2c and activation of DNA synthesis, other proteins in addition
to p6 are required, protein p6 could function by saturating the
nonspecific DNA sequence, thereby ensuring that the concentration of
the corresponding proteins (the transcriptional regulator p4 or DNA
polymerase) remains high enough to successfully find its targets even
when the amount of DNA increases. We cannot exclude an architectural
role of p6 in transcription regulation through the transient flexing of
the DNA upon its binding, which most probably increases the interaction between the two p4 dimers, and between these and the DNA backbone, thereby enhancing p4 binding affinity.
Prokaryotic cells contain proteins involved in the organization and
compaction of their chromosomal DNA, among them, proteins HU and H-NS
of Escherichia coli (21) and HBsu of B. subtilis (13). Bacteriophage
29 protein p6 shares
several properties with these proteins; like them, it is small and
basic, it forms dimers in solution and binds double-stranded DNA
depending on structural features rather than by sequence recognition,
and it is a global transcriptional regulator which represses its own promoter both in vivo (this paper) and in vitro (6).
Therefore, protein p6 is an excellent tool for analyzing and
elucidating the nonspecific but precise function of the so-called
histone-like prokaryotic proteins.
 |
ACKNOWLEDGMENTS |
This investigation was aided by research grants 2R01 GM27242-20
from the National Institutes of Health and PB98-0645 from the
Dirección General de Investigación de Ciencia y
Tecnología and an institutional grant from the Fundación
Ramón Areces.
We thank F. Rojo for critical reading of the manuscript and J. M. Lázaro and L. Villar for purification of proteins.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Centro de
Biología Molecular "Severo Ochoa" (CSIC-UAM), Universidad
Autónoma, Canto Blanco, 28049 Madrid, Spain. Phone: 34-91 397 8435. Fax: 34-91 397 84 90. E-mail: msalas{at}cbm.uam.es.
 |
REFERENCES |
| 1.
|
Abril, A.,
M. Salas,
J. M. Andreu,
J. M. Hermoso, and G. Rivas.
1997.
Phage 29 protein p6 is in a monomer-dimer equilibrium that shifts to higher association states at the millimolar concentration found in vivo.
Biochemistry
36:11901-11908[CrossRef][Medline].
|
| 2.
|
Barthelemy, I.,
R. P. Mellado, and M. Salas.
1989.
In vitro transcription of bacteriophage 29 DNA: inhibition of early promoter by the viral replication protein p6.
J. Virol.
63:460-462[Abstract/Free Full Text].
|
| 3.
|
Barthelemy, I.,
M. Salas, and R. P. Mellado.
1987.
In vivo transcription of bacteriophage 29 DNA: transcription termination.
J. Virol.
61:1751-1755[Abstract/Free Full Text].
|
| 4.
|
Bravo, A., and M. Salas.
1997.
Initiation of bacteriophage 29 DNA replication in vivo: assembly of a membrane-associated multiprotein complex.
J. Mol. Biol.
269:102-112[CrossRef][Medline].
|
| 5.
|
Carrascosa, J. L.,
A. Camacho,
F. Moreno,
F. Jiménez,
R. P. Mellado,
E. Viñuela, and M. Salas.
1976.
Bacillus subtilis bacteriophage 29. Characterization of gene products and functions.
Eur. J. Biochem.
66:229-241[Medline].
|
| 6.
|
Elías-Arnanz, M., and M. Salas.
1999.
Functional interactions between a phage histone-like protein and a transcriptional factor in regulation of 29 early-late transcriptional switch.
Genes Dev.
13:2502-2513[Abstract/Free Full Text].
|
| 7.
|
Guo, P.,
S. Erikson, and D. Anderson.
1987.
A small RNA is required for in vivo packaging of bacteriophage 29 DNA.
Science
236:690-694[Abstract/Free Full Text].
|
| 8.
|
Gutiérrez, C.,
R. Freire,
M. Salas, and J. M. Hermoso.
1994.
Assembly of phage 29 genome with viral protein p6 into a compact complex.
EMBO J.
13:169-176.
|
| 9.
|
Hermoso, J. M.,
R. Freire,
A. Bravo,
C. Gutiérrez,
M. Serrano, and M. Salas.
1994.
DNA structure in the nucleoprotein complex that activates replication of phage 29.
Biophys. Chem.
50:183-189[CrossRef][Medline].
|
| 10.
|
Jiménez, F.,
A. Camacho,
J. Torre,
E. Viñuela, and M. Salas.
1977.
Assembly of Bacillus subtilis phage 29: mutants in the cistrons coding for the non-structural proteins.
Eur. J. Biochem.
73:57-72[Medline].
|
| 11.
|
Meijer, W.,
P. Lewis,
J. Errington, and M. Salas.
2000.
Dynamic relocalization of phage 29 DNA during replication and the role of the viral protein p16.7.
EMBO J.
19:4182-4190[CrossRef][Medline].
|
| 12.
|
Mellado, R. P.,
E. Viñuela, and M. Salas.
1976.
Isolation of a strong suppressor of nonsense mutations in Bacillus subtilis.
Eur. J. Biochem.
65:213-223[Medline].
|
| 13.
|
Micka, B.,
N. Groch,
U. Heinemann, and M. A. Marahiel.
1991.
Molecular cloning, nucleotide sequence, and characterization of the Bacillus subtilis gene encoding the DNA-binding protein HBsu.
J. Bacteriol.
173:3191-3198[Abstract/Free Full Text].
|
| 14.
|
Monsalve, M.,
M. Mencía,
F. Rojo, and M. Salas.
1995.
Transcription regulation in Bacillus subtilis phage 29: expression of the viral promoters throughout the infection cycle.
Virology
20:23-31.
|
| 15.
|
Moreno, F.,
A. Camacho,
E. Viñuela, and M. Salas.
1974.
Suppressor-sensitive mutants and genetic map of Bacillus subtilis bacteriophage 29.
Virology
62:1-16[CrossRef][Medline].
|
| 16.
|
Reilly, B. E.,
V. M. Zeece, and D. L. Anderson.
1973.
Genetic study of suppressor-sensitive mutants of the Bacillus subtilis bacteriophage 29.
J. Virol.
11:756-760[Abstract/Free Full Text].
|
| 17.
|
Rojo, F.,
M. Mencía,
M. Monsalve, and M. Salas.
1998.
Transcription activation and repression by interaction of a regulator with the subunit of RNA polymerase: the model of phage 29 protein p4.
Prog. Nucleic Acid Res. Mol. Biol.
60:29-46[Medline].
|
| 18.
|
Salas, M.,
J. T. Miller,
J. Leis, and M. L. DePamphilis.
1996.
Mechanisms for priming DNA synthesis, p. 131-176.
In
M. L. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 19.
|
Salas, M., and F. Rojo.
1993.
Replication and transcription of bacteriophage 29 DNA, p. 843-857.
In
A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.
|
| 20.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 21.
|
Schmid, B. M.
1990.
More than just "histone-like" proteins.
Cell
63:451-453[CrossRef][Medline].
|
| 22.
|
Serrano, M.,
C. Gutiérrez,
M. Salas, and J. M. Hermoso.
1993.
Superhelical path of the DNA in the nucleoprotein complex that activates the initiation of phage 29 DNA replication.
J. Mol. Biol.
230:248-259[CrossRef][Medline].
|
| 23.
|
Serrano, M.,
M. Salas, and J. M. Hermoso.
1990.
A novel nucleoprotein complex at a replication origin.
Science
248:1012-1016[Abstract/Free Full Text].
|
| 24.
|
Serrano, M.,
J. Gutiérrez,
I. Prieto,
J. M. Hermoso, and M. Salas.
1989.
Signals at the bacteriophage 29 DNA replication origins required for protein p6 binding and activity.
EMBO J.
8:1879-1885[Medline].
|
| 25.
|
Whiteley, H. R.,
W. D. Ramey,
G. B. Spiegelman, and R. D. Holder.
1986.
Modulation of in vivo and in vitro transcription of bacteriophage 29 early genes.
Virology
155:392-401[CrossRef][Medline].
|
Journal of Bacteriology, December 2000, p. 6927-6932, Vol. 182, No. 24
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Meijer, W. J. J., Horcajadas, J. A., Salas, M.
(2001). {phi}29 Family of Phages. Microbiol. Mol. Biol. Rev.
65: 261-287
[Abstract]
[Full Text]
-
Camacho, A., Salas, M.
(2001). Repression of Bacteriophage phi 29 Early Promoter C2 by Viral Protein p6 Is Due to Impairment of Closed Complex. J. Biol. Chem.
276: 28927-28932
[Abstract]
[Full Text]